Pathogenesis of COPD
Pathologic changes in chronic obstructive pulmonary disease (COPD) happen in the large (central) airway routes, the little (peripheral) bronchioles, and the lung parenchyma. Most instances of COPD are the consequence of introduction to noxious stimuli,, regularly tobacco smoke. The normal inflammatory response is enhanced in people inclined to COPD advancement. Increased quantities of activated polymorphonuclear leukocytes and macrophages discharge elastases in a way that can't be neutralized viably by antiproteases, bringing about lung destruction.
- Chronic bronchitis
- Emphysema
- Refractory asthma
Related Conference of Pathogenesis of COPD
October 22-23, 2025
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
November 24-25, 2025
17th International Conference on Chronic Obstructive Pulmonary Disease
Barcelona, Spain
Pathogenesis of COPD Conference Speakers
Recommended Sessions
- Asthma and allergy
- Cardiovascular Risk and COPD
- CO-Morbidities in COPD
- COPD Exacerbations
- COPD Management
- Epidemiology of COPD
- Interstitial Lung Disease
- Lung cancer
- Lung Diseases
- Lung Transplantation
- Occupational & Environmental lung Disease
- Pathogenesis of COPD
- Prevention of COPD
- Pulmonary Hypertension
- Pulmonary, Critical care and Sleep
- Respiratory Infections
- Therapeutic Devices and Evaluation
Related Journals
Are you interested in
- Advances in Tuberculosis Diagnosis, Treatment, and Prevention - Tuberculosis-2025 (France)
- Asthma - Pulmonary Meet 2025 (France)
- Asthma and Allergy - COPD CONGRESS-2025 (Italy)
- Asthma and COPD - COPD_2025 (Spain)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Cardio Pulmonary Disorders - COPD CONGRESS-2025 (Italy)
- Chronic bronchitis - COPD CONGRESS-2025 (Italy)
- Chronic Bronchitis - Pulmonary Meet 2025 (France)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Chronic Obstructive Pulmonary Disease - COPD_2025 (Spain)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- Co-Morbidities of COPD - COPD_2025 (Spain)
- Community-based Approaches to TB and Lung Health Awareness - Tuberculosis-2025 (France)
- COPD - Pulmonary Meet 2025 (France)
- COPD and Air Pollution - COPD CONGRESS-2025 (Italy)
- COPD and Cardiovascular Diseases - COPD_2025 (Spain)
- COPD Complications - COPD_2025 (Spain)
- COPD Exacerbations - COPD_2025 (Spain)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Pathogenesis - COPD CONGRESS-2025 (Italy)
- COPD Pathogenesis - COPD_2025 (Spain)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD Therapeutics - COPD_2025 (Spain)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- COPD: Sign and Symptoms - COPD_2025 (Spain)
- Cystic Fibrosis - Pulmonary Meet 2025 (France)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Depression and Anxiety in COPD - COPD CONGRESS-2025 (Italy)
- Depression and anxiety in COPD - COPD_2025 (Spain)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Diagnosis and Treatment of COPD - COPD CONGRESS-2025 (Italy)
- Digital Health Technologies for Respiratory Disease Management - Tuberculosis-2025 (France)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS-2025 (Italy)
- Drug Discovery of COPD - COPD_2025 (Spain)
- Early Diagnosis and Biomarkers in Respiratory Diseases - Tuberculosis-2025 (France)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS-2025 (Italy)
- Emerging Respiratory Threats and Pandemic Preparedness - Tuberculosis-2025 (France)
- Emphysema - COPD CONGRESS-2025 (Italy)
- Emphysema - Pulmonary Meet 2025 (France)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Epidemiology of COPD - COPD_2025 (Spain)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Genetic risk factor of COPD - COPD_2025 (Spain)
- Genetics and Susceptibility to Tuberculosis and Lung Diseases - Tuberculosis-2025 (France)
- Global Efforts to Eliminate Tuberculosis by 2030 - Tuberculosis-2025 (France)
- Hospital-acquired Infections and Respiratory Care - Tuberculosis-2025 (France)
- Impact of Smoking and Environmental Factors on Lung Health - Tuberculosis-2025 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2025 (France)
- Interstitial lung disease - Pulmonary Meet 2025 (France)
- Latent Tuberculosis: Diagnosis, Treatment, and Control - Tuberculosis-2025 (France)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD CONGRESS-2025 (Italy)
- Lung Cancer - Pulmonary Meet 2025 (France)
- Lung cancer - COPD_2025 (Spain)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS-2025 (Italy)
- Lung Health: Emerging Trends and Challenges - Tuberculosis-2025 (France)
- Lung problems - Pulmonary Meet 2025 (France)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Lung Transplantation - COPD CONGRESS-2025 (Italy)
- Lung transplantation - Pulmonary Meet 2025 (France)
- Multidrug-Resistant Tuberculosis (MDR-TB) and Novel Therapies - Tuberculosis-2025 (France)
- Neonatal and Maternal Respiratory Health - Tuberculosis-2025 (France)
- Novel Therapies and Drug Development for Tuberculosis - Tuberculosis-2025 (France)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pathophysiology of COPD - COPD_2025 (Spain)
- Pediatric Neonatal Care in COPD - COPD CONGRESS-2025 (Italy)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2025 (Spain)
- Pediatric Pulmonology & Critical care - COPD CONGRESS-2025 (Italy)
- Pediatric Tuberculosis and Respiratory Health - Tuberculosis-2025 (France)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Pleural Diseases - Pulmonary Meet 2025 (France)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2025 (France)
- Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Pulmonary diseases - COPD CONGRESS-2025 (Italy)
- Pulmonary diseases-treatment and therapies - COPD_2025 (Spain)
- Pulmonary Hypertension - Pulmonary Meet 2025 (France)
- Pulmonary Hypertension - COPD_2025 (Spain)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Pulmonary Rehabilitation - COPD CONGRESS-2025 (Italy)
- Pulmonary Rehabilitation - Pulmonary Meet 2025 (France)
- Pulmonary Rehabilitation and Holistic Care for Respiratory Diseases - Tuberculosis-2025 (France)
- Pulmonary vascular disease - Pulmonary Meet 2025 (France)
- Pulmonology - Pulmonary Meet 2025 (France)
- Respiratory and sleep Medicine - COPD CONGRESS-2025 (Italy)
- Respiratory Disorders - Pulmonary Meet 2025 (France)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Infections and Global Public Health Concerns - Tuberculosis-2025 (France)
- Respiratory Infections and Global Public Health Concerns - Tuberculosis-2025 (France)
- Respiratory Tract Infections - COPD CONGRESS-2025 (Italy)
- Respiratory Tract Infections - Pulmonary Meet 2025 (France)
- Role of Artificial Intelligence in Tuberculosis Diagnosis - Tuberculosis-2025 (France)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Self-Management and Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Self-Management and Prevention of COPD - COPD_2025 (Spain)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2025 (France)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Spirometry - COPD CONGRESS-2025 (Italy)
- Stages & Severity on Lung Diseases - COPD CONGRESS-2025 (Italy)
- Tobacco control - COPD CONGRESS-2025 (Italy)
- Tuberculosis - Pulmonary Meet 2025 (France)
- Tuberculosis and HIV Co-infection: Challenges and Treatment - Tuberculosis-2025 (France)
- Tuberculosis Prevention and Global Public Health Strategies - Tuberculosis-2025 (France)
- Types of COPD - COPD CONGRESS-2025 (Italy)
- Types of COPD - COPD_2025 (Spain)